• Tidak ada hasil yang ditemukan

PUSAT DIALISIS SEJATI SUBANG

N/A
N/A
Protected

Academic year: 2019

Membagikan "PUSAT DIALISIS SEJATI SUBANG"

Copied!
8
0
0

Teks penuh

(1)

PUSAT DIALISIS SEJATI SUBANG

(Company No. 398471 -PA)

(Incorporated in Malaysia)

MANAGEMENT REPORT AND FINANCIAL STATEMENTS

31 December 2014

MANAGEMENT ACCOUNT

(2)

CORPORATE INFORMATION

BOARD OF DIRECTORS : ARSAD BIN RAHMAN

TAN KEE KONG

COMPANY SECRETARY : TAN MOON MENG (LS NO.10004)

AUDITORS : YOONG YEE & CO (AXX 1001)

PRINCIPAL PLACE OF BUSINESS : No. 16 JALAN KELULI AK7/AK, PUSAT PERNIAGAAN BUKIT RAJA, SEKSYEN 7, 40000 SHAH ALAM, SELANGOR

(3)

DIRECTORS’ REPORT

FOR THE ENDED 31 DECEMBER 2014

The directors hereby submit their management account report together with the financial statements of the Company for the ended 31 December 2014

PRINCIPAL ACTIVITIES

The principal activities of the Company are to carry business in providing facilities and services in relation to dialysis for patient care. There have been no significant changes in the nature of the activities during the year.

RESULTS

RM

Profit for the year 55,729.50

RESERVES AND PROVISIONS

There were no material transfers to or from reserves or provisions during the financial year.

SHARES AND DEBENTURES

During the year, the Company has not issue any ordinary shares: The Company did not issue any debentures during the year.

SHARE OPTIONS

No options have been granted by the Company to any parties during the year to take up unissued shares of the Company.

DIRECTORS

The directors who held office since the date of the last report are: ARSAD BIN RAHMAN

(4)

DIRECTORS’ BENEFITS

During and at the end of the year, no arrangements subsisted to which the Company is a party, with the object or objects of enabling directors of the Company to acquire benefits by means of the acquisition of shares in, or debentures of, the Company or any other body corporate.

Since the end of the previous year, no director has received or become entitled to receive a benefit (other than a benefit included in the aggregate amount of emoluments received or due and receivable by the directors shown in the financial statements or the fixed salary of a full-time employee of the Company) by reason of a contract made by the Company or a related corporation with the director or with a firm of which the director is a member, or with a company in which the director has a substantial financial interest.

DIRECTORS’ INTERESTS

According to the register of directors’ shareholding, the interests of directors in office at the end of the year in the ordinary shares of the Company are as follows:

Number of Ordinary Shares of RM1 Each had been written-off and that adequate allowance had been made for doubtful debts; and

(b) to ensure that any current assets which were unlikely to be realised at their book values in the ordinary course of business have been written down to their estimated realisable values.

As of the date of this report, the directors are not aware of any circumstances:

(a) which would render the amount written off for bad debts or the amount of the allowance for doubtful debts inadequate to any substantial extent in the financial statements of the Company; and (b) which would render the values attributed to current assets in the financial statements of the

(5)

(d) not otherwise dealt with in this report or financial statements which would render any amount stated in the financial statements of the Company misleading.

As of the date of this report, there does not exist:

(a) any charge on the assets of the Company which has arisen since the end of the year and secures the liability of any other person; or

(b) any contingent liability of the Company which has arisen since the end of the year.

No contingent or other liability has become enforceable, or is likely to become enforceable within the period of nine months after the end of the year which, in the opinion of the directors, will or may substantially affect the ability of the Company to meet its obligations as and when they fall due.

In the opinion of the directors, no item, transaction or event of a material and unusual nature has arisen in the interval between the end of the year and the date of this report which is likely to affect substantially the results of the operations of the Company for the year.

AUDITORS / MANAGEMENT ACCOUNT

The Management account was prepared by auditors, Messrs. YOONG YEE & CO., Signed on behalf of the Board of Directors,

PUSAT DIALISIS SEJATI SUBANG Director

Kuala Lumpur

(6)
(7)

(Incorporated in Malaysia)

DETAILED INCOME STATEMENT

FOR THE YEAR ENDED 31 DECEMBER 2014

2014 2013

RM RM

REVENUE 410,000.00 162,862.00

LESS: COST OF SALES

Opening inventories 4,188.50 4,213.50 Nephrology fees 10,500.00 10,460.00 Meal for patient 1,345.00 - Purchases 151,700.00 33,957.51

167,733.50 48,631.01 Less: Closing inventories (9,850.00) (4,188.50)

157,883.50 44,442.51

GROSS PROFIT 252,116.50 118,419.49

LESS: OPERATING EXPENSES (196,387.00) (175,210.89)

(8)

Referensi

Dokumen terkait

Viskositas akhir yang tinggi terjadi pada genotipe V4D2-1(2) (Varian genotipe Adira 4-1) yaitu 2.592 cP yang berkorelasi dengan tingginya kandungan amilosa yang dimiliki

Pada aspek kemampuan mengelompokkan benda sesuai dengan warna ada 11 anak (73,33%) dalam kategori Berkembang Sangat Baik, ada 2 anak (13,33%) dalam kategori Berkembang Sesuai

Panitia Pengadaan Pekerjaan Konstruksi pada Rumah Sakit Jiwa Daerah Jambi akan melaksanakan Pelelangan Umum dengan pascakualifikasi untuk paket pekerjaan konstruksi sebagai

[r]

Sedangkan hasil Uji -t menunjukkan bahwa lingkungan kerja berpengaruh positif dan signifikan terhadap kinerja karyawan, tetapi stress kerja berpengaruh tidak signifikan

[r]

Rp 287.800.000,- (Dua Ratus Delapan Puluh Tujuh Juta Delapan Ratus Ribu Rupiah) Tahun Anggaran 2016, maka dengan ini diumumkan bahwa Pemenang Pelelangan Umum pekerjaan tersebut di

Untuk menyaring database cukup dilakukan dengan cara mengklik tombol daftar pilihan (tombol drop-down) pada nama field (judul kolom) yang diinginkan, kemudian